Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis

OBJECTIVE: The progress of neoadjuvant therapy for resectable locally advanced esophageal cancer has been stagnant. There has been much progress in immunotherapy for advanced esophageal cancer, but the efficacy and safety of neoadjuvant immunotherapy for resectable locally advanced esophageal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jincheng, Zhang, Kun, Liu, Tianzhou, Song, Ying, Hua, Peiyan, Chen, Shu, Li, Jindong, Liu, Yang, Zhao, Yinghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495441/
https://www.ncbi.nlm.nih.gov/pubmed/36158679
http://dx.doi.org/10.3389/fonc.2022.974684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495441/
https://www.ncbi.nlm.nih.gov/pubmed/36158679
http://dx.doi.org/10.3389/fonc.2022.974684

Ejemplares similares